Lexaria Bioscience (@LexariaBioCorp) header
Lexaria Bioscience (@LexariaBioCorp) profile picture

Lexaria Bioscience

@LexariaBioCorp

Lexaria Bioscience Corp is a research-driven company that has developed a patented DehydraTECH™ tech that promotes faster delivery of drugs into the blood $LEXX

lexariabioscience.com/
Joined July 2020
  • Tweets409
  • Following754
  • Followers865
317Media
Photo by Lexaria Bioscience (@LexariaBioCorp)Photo by Lexaria Bioscience (@LexariaBioCorp)Photo by Lexaria Bioscience (@LexariaBioCorp)Photo by Lexaria Bioscience (@LexariaBioCorp)Photo by Lexaria Bioscience (@LexariaBioCorp)Photo by Lexaria Bioscience (@LexariaBioCorp)Photo by Lexaria Bioscience (@LexariaBioCorp)Photo by Lexaria Bioscience (@LexariaBioCorp)Photo by Lexaria Bioscience (@LexariaBioCorp)Photo by Lexaria Bioscience (@LexariaBioCorp)
Lexaria Enters a Material Transfer Agreement With PegBio lexariabioscience.com/2026/0… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes
Image from Lexaria Bioscience (@LexariaBioCorp)
1
2
5
505
Lexaria’s Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule lexariabioscience.com/2026/0… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes
Image from Lexaria Bioscience (@LexariaBioCorp)
1
1
2
719
Lexaria Updates Progress on Human Study #7 lexariabioscience.com/2026/0… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes
Image from Lexaria Bioscience (@LexariaBioCorp)
1
4
6
584
Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs - Amycretin and retatrutide to be tested for compatibility with DehydraTECH lexariabioscience.com/2026/0… #Biotech #DrugDelivery #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes
Image from Lexaria Bioscience (@LexariaBioCorp)
1
1
4
529
Lexaria to Begin New Human Clinical Study in GLP-1 - Contracts signed for Human Pilot Study #7 (GLP-1-H26-7) lexariabioscience.com/2026/0… #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes
Image from Lexaria Bioscience (@LexariaBioCorp)
1
3
447
Lexaria’s Robust Patent Portfolio Continues to Grow - Lexaria receives 5 new patents including 2 for diabetes treatment utilizing GLP-1 drugs lexariabioscience.com/2026/0…
Image from Lexaria Bioscience (@LexariaBioCorp)
1
1
507
Lexaria Announces New R&D Plans for 2026 - Exciting new human and animal studies designed to enhance business opportunities lexariabioscience.com/2026/0… $LEXX #Biotech #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes
Image from Lexaria Bioscience (@LexariaBioCorp)
1
3
7
363
Lexaria Announces Positive Final Results From Human Pilot Study #5 lexariabioscience.com/2026/0… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes
Image from Lexaria Bioscience (@LexariaBioCorp)
1
2
2
5
1,704
Lexaria Awarded Six Additional Patents - Lexaria now has 60 patents granted around much of the world lexariabioscience.com/2026/0… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes
Image from Lexaria Bioscience (@LexariaBioCorp)
1
2
740
Lexaria Releases Annual Letter from the CEO lexariabioscience.com/2026/0… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes
Image from Lexaria Bioscience (@LexariaBioCorp)
3
3
377
Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4 lexariabioscience.com/2025/1… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes
Image from Lexaria Bioscience (@LexariaBioCorp)
3
1
6
1,696
Primary Endpoint Successfully Achieved in Lexaria’s Phase 1b Study GLP-1-H24-4 lexariabioscience.com/2025/1… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes
Image from Lexaria Bioscience (@LexariaBioCorp)
7
4
2
6
1,054
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended lexariabioscience.com/2025/1… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes
Image from Lexaria Bioscience (@LexariaBioCorp)
4
1
1
9
992
Lexaria Bioscience Corp. Provides Strategic Update lexariabioscience.com/2025/1… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes
Image from Lexaria Bioscience (@LexariaBioCorp)
1
3
407
Lexaria’s Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain lexariabioscience.com/2025/0… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes
Image from Lexaria Bioscience (@LexariaBioCorp)
1
1
5
659
Lexaria’s Phase 1b GLP-1 Study Achieves Important “Last Patient Last Visit” Milestone lexariabioscience.com/2025/0… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes
Image from Lexaria Bioscience (@LexariaBioCorp)
1
1
3
248
GLP-1 “Arms Race” Broadens to Include Dozens of Companies - Lexaria highlights DehydraTECH’s adverse events improvement opportunity lexariabioscience.com/2025/0… $LEXX #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes
Image from Lexaria Bioscience (@LexariaBioCorp)
1
180
Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b Study lexariabioscience.com/2025/0… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes
Image from Lexaria Bioscience (@LexariaBioCorp)
1
5
507
Lexaria’s DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry lexariabioscience.com/2025/0… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes
Image from Lexaria Bioscience (@LexariaBioCorp)
4
325
Lexaria Reaches Patent Milestone – 50 Patents Now Granted Worldwide!! lexariabioscience.com/2025/0… $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #patent
Image from Lexaria Bioscience (@LexariaBioCorp)
1
87

No more items